Vimarsana
Biggest News Aggregation in the World

Page 48 - Cassava Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cassava Sciences Today - Breaking & Trending Today

These Are The Five Best And Worst Performing Small-cap Stocks In September 2022 - Vimarsana News

These Are The Five Best And Worst Performing Small-cap Stocks In September 2022

We have used the September return data from finviz.com to rank the five best and worst performing small-cap stocks in September 2022.

An Overview Of Today's Alzheimer's Disease Development Field - Vimarsana News

An Overview Of Today's Alzheimer's Disease Development Field

Alzheimer's is one of the largest unmet medical needs. Today, there are 139 drugs in clinical trials for Alzheimer's. Click here to read more.

Cassava Sciences Announces Initiation of an Open-label - Vimarsana News

Cassava Sciences Announces Initiation of an Open-label

Alzheimer’s Patients Who Complete Participation in a Phase 3 Study of Simufilam are Eligible to Enroll52-week Study of Simufilam 100 mgUp to 1,600 Patients...

Hedge Fund Manager Chris Brown Gives Himself a 'C' | Institutional Investor - Vimarsana News

Hedge Fund Manager Chris Brown Gives Himself a 'C' | Institutional Investor

Aristides Capital’s long-short funds are down around 4.5 percent this year.

Should you buy Cassava Sciences as the stock continue to soar - Vimarsana News

Should you buy Cassava Sciences as the stock continue to soar

Should you buy Cassava Sciences (NASDAQ:SAVA) as the stock continues to soar? Retail interest in Cassava Sciences stock.

Source: invezz.com